Pulmicort
E506227
Pulmicort is a corticosteroid medication (budesonide) commonly used as an inhaled treatment to control and prevent asthma symptoms.
Statements (31)
| Predicate | Object |
|---|---|
| instanceOf |
brand name drug
ⓘ
inhaled corticosteroid ⓘ |
| advisedWith | mouth rinsing after inhalation ⓘ |
| belongsToDrugClass |
corticosteroids
ⓘ
glucocorticoids ⓘ |
| commonSideEffect |
cough
ⓘ
hoarseness ⓘ oral thrush ⓘ throat irritation ⓘ |
| developedFrom | budesonide NERFINISHED ⓘ |
| fullEffectTime | may take 1 to 2 weeks of regular use ⓘ |
| hasActiveIngredient | budesonide ⓘ |
| hasATCCode | R03BA02 ⓘ |
| hasBrandNameVariant |
Pulmicort Flexhaler
NERFINISHED
ⓘ
Pulmicort Respules NERFINISHED ⓘ |
| hasDosageForm |
dry powder inhaler
ⓘ
inhalation suspension ⓘ |
| hasOnsetOfAction | within 24 hours for some patients ⓘ |
| hasRouteOfAdministration | inhalation ⓘ |
| isMarketedBy | AstraZeneca NERFINISHED ⓘ |
| isNotFor | acute asthma attacks ⓘ |
| mayBeUsedIn | pediatric patients ⓘ |
| mechanismOfAction | anti-inflammatory effect in airways ⓘ |
| reduces |
airway hyperresponsiveness
ⓘ
airway inflammation ⓘ |
| regulatoryStatus | prescription only ⓘ |
| requires | regular use for maximal benefit ⓘ |
| treats | asthma ⓘ |
| usedFor |
control of chronic asthma
ⓘ
maintenance treatment of asthma ⓘ prevention of asthma symptoms ⓘ |
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.